Weave reports Q2 adjusted EPS 2c, consensus 0c

Reports Q2 revenue $58.5M, consensus $57.81M. “Q2 marked another strong quarter for Weave (WEAV), with solid revenue growth, improved gross margins, and increased free cash flow. We are seeing clear momentum across our growth vectors. Specialty Medical has grown to be our second-largest vertical in location count, mid-market traction continues to accelerate, and we launched additional key integrations expanding our reach to thousands of new locations,” said CEO Brett White. “We also closed our acquisition of TrueLark, which delivers AI-powered workflow automation through 24×7 patient engagement. We’re excited to integrate TrueLark into our business, where we see a strong opportunity to enhance our offering and deliver even greater value to our customers.”